Cleemput I - Search Results

1

Belgian methodological guidelines for pharmacoeconomic evaluations: toward standardization of drug reimbursement requests.

Cleemput I, van Wilder P, Huybrechts M, Vrijens F. Cleemput I, et al. Value Health. 2009 Jun;12(4):441-9. doi: 10.1111/j.1524-4733.2008.00469.x. Epub 2008 Nov 11. Value Health. 2009. PMID: 19900251 Free article.

2

A review of the literature on the economics of noncompliance. Room for methodological improvement.

Cleemput I, Kesteloot K, DeGeest S. Cleemput I, et al. Health Policy. 2002 Jan;59(1):65-94. doi: 10.1016/s0168-8510(01)00178-6. Health Policy. 2002. PMID: 11786175 Review.

3

The construct and concurrent validity of the EQ-5D in a renal transplant population.

Cleemput I, Kesteloot K, Moons P, Vanrenterghem Y, Van Hooff JP, Squifflet JP, De Geest S. Cleemput I, et al. Value Health. 2004 Jul-Aug;7(4):499-509. doi: 10.1111/j.1524-4733.2004.74013.x. Value Health. 2004. PMID: 15449642 Free article.

4

The economic implications of non-adherence after renal transplantation.

Cleemput I, Kesteloot K, Vanrenterghem Y, De Geest S. Cleemput I, et al. Pharmacoeconomics. 2004;22(18):1217-34. doi: 10.2165/00019053-200422180-00006. Pharmacoeconomics. 2004. PMID: 15606228

5

Cost-effectiveness of human papillomavirus vaccination in Belgium: do not forget about cervical cancer screening.

Thiry N, De Laet C, Hulstaert F, Neyt M, Huybrechts M, Cleemput I. Thiry N, et al. Among authors: cleemput i. Int J Technol Assess Health Care. 2009 Apr;25(2):161-70. doi: 10.1017/S0266462309090217. Int J Technol Assess Health Care. 2009. PMID: 19366497

6

History of health technology assessment in Belgium.

Cleemput I, Van Wilder P. Cleemput I, et al. Int J Technol Assess Health Care. 2009 Jul;25 Suppl 1:82-7. doi: 10.1017/S0266462309090461. Epub 2009 Jun 8. Int J Technol Assess Health Care. 2009. PMID: 19500438

7

Using threshold values for cost per quality-adjusted life-year gained in healthcare decisions.

Cleemput I, Neyt M, Thiry N, De Laet C, Leys M. Cleemput I, et al. Int J Technol Assess Health Care. 2011 Jan;27(1):71-6. doi: 10.1017/S0266462310001194. Epub 2011 Jan 25. Int J Technol Assess Health Care. 2011. PMID: 21262069 Review.

8

Critical assessment of belgian reimbursement dossiers of orphan drugs.

Denis A, Mergaert L, Fostier C, Cleemput I, Hulstaert F, Simoens S. Denis A, et al. Among authors: cleemput i. Pharmacoeconomics. 2011 Oct;29(10):883-93. doi: 10.2165/11585980-000000000-00000. Pharmacoeconomics. 2011. PMID: 21905759

9

European drug reimbursement systems' legitimacy: five-country comparison and policy tool.

Cleemput I, Franken M, Koopmanschap M, le Polain M. Cleemput I, et al. Int J Technol Assess Health Care. 2012 Oct;28(4):358-66. doi: 10.1017/S0266462312000529. Epub 2012 Sep 17. Int J Technol Assess Health Care. 2012. PMID: 22980497

10

Belgian guidelines for economic evaluations: second edition.

Thiry N, Neyt M, Van De Sande S, Cleemput I. Thiry N, et al. Among authors: cleemput i. Int J Technol Assess Health Care. 2014 Dec;30(6):601-7. doi: 10.1017/S0266462314000725. Int J Technol Assess Health Care. 2014. PMID: 25816826

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

85 results

Search Page

Filters